Citius Pharmaceuticals's total assets for Q1 2026 were $140.39M, an increase of 7.22% from the previous quarter. CTXR total liabilities were $46.92M for the fiscal quarter, a -12.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.